Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in coagulation and platelet reactivity in HIV-1 infected patients switching between abacavir and tenofovir
2013-001685-42Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of abacavir and tenofovir in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Rigshospitalet. Primary endpoint: Platelet aggregation change. Started Jun 2013; status: terminated.
02
Drugs
abacavirtenofovir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2013-001685-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001685-42.